What is a 409A Valuation?

Feb 14, 2023

Societal CDMO Highlights Growth of Existing Customer Business Through Signing of More Than $6 Million in Work Orders During Fourth Quarter of 2022

Feb 14, 2023

Posted by Societal CDMO

Slowey McManus Announces Acquisition of Emerging BioCommunications

Feb 10, 2023

CoSolve: Forging partnerships to solve research challenges

Feb 09, 2023

Posted by AstraZeneca/Alexion/Rare Disease

New Member Announcement – Astrella

Feb 09, 2023

Greenberg Traurig’s Chinh H. Pham on Get Konnected! List of Boston’s 50 Most Influential Asian-American Pacific Islanders

Feb 08, 2023

Posted by Greenberg Traurig, LLP

What Life Sciences Companies Can Expect for Enforcement in 2023

Feb 07, 2023

Early Stage Biotechs: What’s Essential and What’s Not

Feb 06, 2023

Posted by Tunnell Consulting